VYC ‐17. 5L is Safe and Effective in Improving Skin Quality and Volume Deficit of Hands: Results From an 18‐Month Open‐Label Study
Journal of Cosmetic Dermatology · 2026
DOI: 10.1111/jocd.70675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Daniela Greiner-Krüger und 5 weiteren Autor:innen. Beteiligte Einrichtung: MediCorium, Zentrum Für Dermatologie Und Ästhetik, Oberursel, Germany. Hauptthemen laut MEDLINE: Skin Aging, Rejuvenation, Dermal Fillers, Cosmetic Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Allergan Aesthetics, an AbbVie company, Allergan Aesthetics.
Abstract (Originalsprache)
Background
Hands undergo age‐related changes in volume and skin quality. This 18‐month exploratory study evaluated safety and effectiveness of VYC‐17.5 L for hand rejuvenation.
Methods
Participants (≥ 35 years) with moderate‐to‐extreme Allergan Hand Volume Deficit Scale (AHVDS) scores received VYC‐17.5L in both hands on day 1, with optional touch‐up on day 30. Effectiveness was assessed by AHVDS responder rate (≥ 1‐grade improvement from baseline per hand) at months 1, 3 (primary effectiveness timepoint), and at 3‐month intervals through month 18; investigator‐ and participant‐Global Aesthetic Improvement Scale (GAIS); hand Self‐Perception of Age (SPA); and skin quality measurements. Safety was evaluated throughout.
Results
Seventy‐five participants (94.7% female; mean age, 53.89 years) had both hands injected with VYC‐17.5L (median, 2.0 mL/hand), and 60.0% of hands received touch‐up (median, 1.0 mL/hand). The primary endpoint was met: 100.0% of hands were AHVDS responders at month 3. The 100% response rate was maintained through month 6, and the majority of participants (> 65%) were responders through month 18. Most hands (≥ 85%) improved on investigator‐ and participant‐GAIS through month 12. SPA improved by 5 to 6 years. Significant skin quality improvements persisted to 12 months. Twenty‐two (29.3%) participants experienced treatment‐related adverse events; most were mild or moderate in severity with a mean duration of 45.1 days, and none led to study discontinuation.
Conclusion
VYC‐17.5L is an effective treatment for improving hand volume deficit, with aesthetic benefits lasting 18 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MediCorium, Zentrum Für Dermatologie Und Ästhetik, Oberursel, Germany.
- Medical Skincare, Sint-Truiden, Belgium.
- Sylwia Lipko-Godlewska, Praktyka Lekarska, Krakow, Poland.
- Allergan Aesthetics, an AbbVie company, Marlow, UK.
- Allergan Aesthetics, an AbbVie company, Irvine, California, USA.
- Allergan Aesthetics, an AbbVie company, Madrid, Spain.
Förderung
- Allergan Aesthetics, an AbbVie company
- Allergan Aesthetics
Zitieren
APA
Greiner-Krüger, D., Leys, C., Lipko-Godlewska, S., Kerson, G. M., Chawla, S., & de la Guardia, C. (2026). VYC ‐17. 5L is Safe and Effective in Improving Skin Quality and Volume Deficit of Hands: Results From an 18‐Month Open‐Label Study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70675
Vancouver
Greiner-Krüger D, Leys C, Lipko-Godlewska S, Kerson GM, Chawla S, de la Guardia C. VYC ‐17. 5L is Safe and Effective in Improving Skin Quality and Volume Deficit of Hands: Results From an 18‐Month Open‐Label Study. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70675
BibTeX
@article{GreinerKrger2026,
author = {Greiner-Krüger, Daniela and Leys, Christophe and Lipko-Godlewska, Sylwia and Kerson, Graeme M and Chawla, Smita and de la Guardia, Carola},
title = {VYC ‐17. 5L is Safe and Effective in Improving Skin Quality and Volume Deficit of Hands: Results From an 18‐Month Open‐Label Study},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
doi = {10.1111/jocd.70675}
}
EUVIMED